Michela Visintin - Concepedia

Author

Michela Visintin

Scuola Internazionale Superiore di Studi Avanzati ORCID

Also Known As

M VISINTIN, M. Visintin, Michela Visintin, Visintin, Michela

Publications

Citations

H-Index

Concepts

All Affiliations

Scuola Internazionale Superiore di Studi Avanzati AREA Science Park University of Siena European Brain Research Institute Institute for Macromolecular Studies

About

Michela Visintin is an author at Scuola Internazionale Superiore di Studi Avanzati specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	391
2	Engineering	2	2	26
3	Natural Sciences	2	2	30
4	Allergy	1	1	131
5	Biochemistry	1	1	20

Michela Visintin

Publications

892

Citations

H-Index

Page 1

	Year	Citations
The Neuronal Microtubule‐Associated Protein Tau Is a Substrate for Caspase‐3 and an Effector of Apoptosis Luisa Fasulo, Gabriele Ugolini, Michela Visintin, Journal of Neurochemistry	2000	192
Selection of antibodies for intracellular function using a two-hybrid<i>in vivo</i>system Michela Visintin, Eric Tse, Håkan Axelson, Proceedings of the National Academy of Sciences	1999	174
The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies Michela Visintin, Giovanni Settanni, Amos Maritan, Journal of Molecular Biology AllergyImmunoengineeringImmunologyConsensus SequenceAntibody Screening	2002	131
Direct in Vivo Intracellular Selection of Conformation-sensitive Antibody Domains Targeting Alzheimer's Amyloid-β Oligomers Giovanni Meli, Michela Visintin, Isabella Cannistraci, Journal of Molecular Biology Neurodegenerative DiseasesAlzheimer's DiseaseProtein FoldingMolecular BiologyDegenerative Pathology	2009	64
Effects of intrabodies specific for rotavirus NSP5 during the virus replicative cycle Fulvia Vascotto, Michela Campagna, Michela Visintin, Journal of General Virology Viral ReplicationMolecular VirologyVirus Replicative CyclePathogenesisViral Pathogenesis	2004	58
Targeting of ADAMTS5's ancillary domain with the recombinant mAb CRB0017 ameliorates disease progression in a spontaneous murine model of osteoarthritis Riccardo Chiusaroli, Marcella Visentini, Chiara Galimberti, Osteoarthritis and Cartilage InflammationRheumatologySclerostinAutoimmune DiseaseSpontaneous Murine Model	2013	55
In vivo selection of intrabodies specifically targeting protein–protein interactions: A general platform for an “undruggable” class of disease targets☆ Michela Visintin, Teresa Melchionna, Isabella Cannistraci, Journal of Biotechnology Protein–protein InteractionsDrug TargetDrug TargetingMedicineImmunology	2008	31
A novel intracellular antibody against the E6 oncoprotein impairs growth of human papillomavirus 16-positive tumor cells in mouse models Carla Amici, Michela Visintin, Francesca Verachi, Oncotarget	2016	28
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19 Luigi Aurisicchio, Nadia Brambilla, Marina Elena Cazzaniga, Molecular Therapy	2022	24
Intracellular Single-Chain Variable Fragments Directed to the Src Homology 2 Domains of Syk Partially Inhibit FcεRI Signaling in the RBL-2H3 Cell Line Stéphanie Dauvillier, Peggy Mérida, Michela Visintin, The Journal of Immunology	2002	20

Page 1